Table 3.
Predictors of mortality in COVID-19
| Variables | OR (95% CI) | AOR (95% CI) |
| Demographics and clinical characteristics* | ||
| Age (years) | ||
| >60 | 12.19 (4.11-36.13) | 5.81 (1.55-21.80) |
| ≤60 | 1 | 1 |
| Smoker (v/s non-smoker) | 6.77 (2.52-18.21) | 3.62 (1.05-12.46) |
| Comorbidities (present v/s absent) | ||
| Hypertension | 6.77 (2.52-18.21) | 2.39 (0.65-8.83) |
| Diabetes Mellitus | 5.81 (1.91-17.71) | 1.47 (0.35-6.19) |
| Ischemic Heart Disease | 11.52 (3.39-39.06) | 4.32 (1.02-18.38) |
| Fatigue (present v/s not present) | 5.56 (1.92-16.09) | 2.01 (0.53-7.56) |
| Laboratory Parameters# | ||
| SGPT (U/L) | ||
| ≥40 | 5.00 (1.89-13.25) | 1.31 (0.26-6.59) |
| <40 | 1 | 1 |
| Serum Creatinine (mg/dl) | ||
| ≥1.2 | 5.53 (1.72-17.78) | 0.12 (0.01-2.12) |
| <1.2 | 1 | 1 |
| D-Dimer (ug/ml) | ||
| >1 | 16.04 (4.99-51.54) | 7.24 (1.16-45.16) |
| ≤1 | 1 | 1 |
| LDH (U/L) | ||
| ≥250 | 35.29 (7.73-161.09) | 9.08 (1.17-70.67) |
| <250 | 1 | 1 |
| Creatinine Kinase (U/L) | ||
| ≥185 | 7.42 (2.72-20.20) | 4.02 (0.32-49.92) |
| <185 | 1 | 1 |
| IL-6 (pg/ml) | ||
| >37.9 | 23.74 (6.50-86.76) | 3.04 (0.56-16.64) |
| ≤37.9 | 1 | 1 |
| PT (secs) | ||
| ≥16 | 5.81 (1.91-17.71) | 2.54 (0.32-20.04) |
| <16 | 1 | 1 |
| Lymphocytes 109 per L | ||
| <1.46 | 15.20 (4.74-48.72) | 8.95 (1.59-50.27) |
| ≥1.46 | 1 | 1 |
| *R2= 0.483, Hosmer-Lemeshow; p=0.629, #R2= 0.685, Hosmer-Lemeshow; p=0.640 | ||